| dc.creator | Fuentes G,Patricio | |
| dc.creator | Slachevsky Ch,Andrea | |
| dc.date | 2005-02-01 | |
| dc.date.accessioned | 2020-02-17T15:34:39Z | |
| dc.date.available | 2020-02-17T15:34:39Z | |
| dc.identifier | https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200012 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/131452 | |
| dc.description | Dementia in general, especially Alzheimer disease and vascular dementia, are diseases of high prevalence with severe socio-economic consequences in all countries. In recent years, due to the obtention of new pharmaceutical products acting on different brain neurotransmitters, there has been important changes in the therapy of these diseases. Although these drugs do not stop disease progression, there is consistent evidence of their usefulness in cognitive, behavioral and functional domains and of their pharmaco-economical justification. This article reviews the main drugs available for Alzheimer disease and some future therapeutic perspectives (Rev Méd Chil 2005; 133: 224-30) | |
| dc.format | text/html | |
| dc.language | es | |
| dc.publisher | Sociedad Médica de Santiago | |
| dc.relation | 10.4067/S0034-98872005000200012 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | Revista médica de Chile v.133 n.2 2005 | |
| dc.subject | Alzheimer disease | |
| dc.subject | Dementia | |
| dc.subject | Neurotransmitters | |
| dc.title | Enfermedad de Alzheimer: Actualización en terapia farmacológica | |
